American Medical Women's Association's commitment to advancing menopausal health equity and awareness

• by Meghan Etsey, Rhea Manohar, Aida Mansour, Leah Liszak, Chelsea Oppong, Sarv Raafati, Kiana Wells, Vashti Price, Vaishnavi J. Patel, Teresa Lazar, Ariela L. Marshall, Rosy Thachil, Brianna Clark, Roberta Gebhard

• July 3, 2026

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.

• by Kathryn Wighton

• May 21, 2026

• 2 min

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

• by Kerri Miller

• May 8, 2026

• 14 min

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

• by Kathryn Wighton

• June 16, 2026

• 5 min